We are live on
!
Find out more
CCM
CAAS Capital Management Portfolio holdings
AUM
$934M
1-Year Est. Return
1.45%
This Fund
S&P 500
This Quarter
Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
(+145%)
Cap. Flow
+$4.78B
Cap. Flow
% of AUM
45.54%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$153M |
| 2 |
Sunrun
RUN
|
+$94.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$83.8M |
| 4 |
Dynatrace
DT
|
+$67.2M |
| 5 |
Consolidated Edison
ED
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$71.8M |
| 2 |
10x Genomics
TXG
|
+$62.3M |
| 3 |
Caesars Entertainment
CZR
|
+$60.8M |
| 4 |
Denali Therapeutics
DNLI
|
+$53.1M |
| 5 |
PENN Entertainment
PENN
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Healthcare | 6.25% |
| 3 | Communication Services | 2.7% |
| 4 | Consumer Discretionary | 2.07% |
| 5 | Financials | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
PUT
Boston Scientific
BSX
$71.4B
| $2.16M | 0.02% |
+60,000
| New | +$2.16M |
|
|
TWCTU
477
DELISTED
TWC Tech Holdings II Corp. Unit
TWCTU
| $2.15M | 0.02% |
200,000
| – | – |
|
|
ACACU
478
DELISTED
Acies Acquisition Corp Unit
ACACU
| $2.14M | 0.02% |
+200,000
| New | +$2.04M |
|
|
FCACU
479
DELISTED
Falcon Capital Acquisition Corp. Unit
FCACU
| $2.14M | 0.02% |
200,000
| – | – |
|
480
Talos Energy
TALO
$2.35B
| $2.13M | 0.02% |
+257,828
| New | +$2.01M |
|
481
Hydrofarm Holdings
HYFM
$8.77M
| $2.1M | 0.02% |
+4,000
| New | +$2.09M |
|
482
GE Aerospace
GE
$389B
| $2.07M | 0.02% |
+38,412
| New | +$1.72M |
|
|
DFS
483
PUT
DELISTED
Discover Financial Services
DFS
| $2.04M | 0.02% |
+22,500
| New | +$1.68M |
|
484
Noodles & Co
NDLS
$108M
| $2.04M | 0.02% |
+32,236
| New | +$1.99M |
|
485
PUT
Franco-Nevada
FNV
$44.6B
| $2.03M | 0.02% |
16,200
| – | – |
|
486
CALL
Bloom Energy
BE
$67.4B
| $2.01M | 0.02% |
+70,000
| New | +$1.49M |
|
487
Merck
MRK
$317B
| $2M | 0.02% |
25,646
-92,453
| -78% | -$7.07M |
|
488
Gilead Sciences
GILD
$162B
| $1.98M | 0.02% |
+34,000
| New | +$2.05M |
|
489
CALL
Targa Resources
TRGP
$57.6B
| $1.98M | 0.02% |
+75,000
| New | +$1.6M |
|
490
Baidu
BIDU
$37.1B
| $1.92M | 0.02% |
+8,898
| New | +$1.32M |
|
491
PUT
American International
AIG
$42.4B
| $1.89M | 0.02% |
50,000
| – | – |
|
492
PUT
ConocoPhillips
COP
$142B
| $1.89M | 0.02% |
+47,300
| New | +$1.74M |
|
493
Vale
VALE
$62.6B
| $1.89M | 0.02% |
+112,500
| New | +$1.5M |
|
494
PUT
GameStop
GME
$8.63B
| $1.88M | 0.02% |
+400,000
| New | +$1.38M |
|
|
CBIO
495
Crescent Biopharma
CBIO
$610M
| $1.88M | 0.02% |
+5,002
| New | +$1.75M |
|
|
496
CALL
GameStop
GME
$8.63B
| $1.88M | 0.02% |
+398,400
| New | +$1.37M |
|
|
ALPN
497
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.87M | 0.02% |
+148,200
| New | +$1.45M |
|
498
PUT
Philip Morris
PM
$293B
| $1.86M | 0.02% |
+22,500
| New | +$1.75M |
|
|
ONC
499
BeOne Medicines Ltd
ONC
$36.7B
| $1.84M | 0.02% |
+7,126
| New | +$1.96M |
|
|
500
CALL
ConocoPhillips
COP
$142B
| $1.83M | 0.02% |
+45,700
| New | +$1.68M |
|
Similar funds
CIG
TAM
WCF
CHP
SWC
KTA
LC
SBIA
CAAS Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.
- CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
- CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
- CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
- CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
- CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
- CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
- CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.
Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.